Nano-X Imaging LTD. (NNOX) — SEC Filings

Overview

Nano-X Imaging LTD. (NNOX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a EFFECT filed on Mar 31, 2026: Nano-X Imaging Ltd. filed an EFFECT form with the SEC on March 31, 2026, indicating the effectiveness of a filing related to Act 33, File No. 333-294302. The company's business address is OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA L3 4970602.

Sentiment Summary

Across 41 filings, the sentiment breakdown is: 5 bullish, 1 bearish, 34 neutral, 1 mixed. The dominant filing sentiment for Nano-X Imaging LTD. is neutral.

Filing Type Overview

Nano-X Imaging LTD. (NNOX) has filed 1 4, 32 6-K, 1 EFFECT, 1 F-3/A, 2 20-F, 3 SC 13G, 1 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (41)

• 6-K Filing — 6-K · Apr 20, 2026
• Nano-X Imaging Filing Becomes Effective — EFFECT · Mar 31, 2026 Risk: low
  Nano-X Imaging Ltd. filed an EFFECT form with the SEC on March 31, 2026, indicating the effectiveness of a filing related to Act 33, File No. 333-294302. The co
• Nano-X Imaging Files F-3/A Amendment for Debt Securities — F-3/A · Mar 26, 2026 Risk: medium
  Nano-X Imaging Ltd. filed an amendment (AMENDMENT NO. 1) to its F-3 registration statement on March 26, 2026. This filing includes documentation related to debt
• NNOX: Insider Daniel Ran Reports Change in Ownership — 4 · Mar 25, 2026
  This Form 4 filing, dated March 25, 2026, indicates a change in beneficial ownership for Daniel Ran, a reporting person for Nano-X Imaging Ltd. (NNOX). While th
• Nano-X Imaging Ltd. Holds Annual Shareholder Meeting — 6-K · Dec 29, 2025 Risk: low
  Nano-X Imaging Ltd. held its Annual General Meeting of Shareholders on December 23, 2025, at its offices in Petach Tikva, Israel. Shareholders voted on and appr
• Nano-X Imaging Annual Meeting Adjourned Due to Lack of Quorum — 6-K · Dec 22, 2025 Risk: low
  Nano-X Imaging Ltd. held its Annual General Meeting of Shareholders on December 22, 2025, but it was adjourned for one day due to a lack of quorum. The meeting
• 6-K Filing — 6-K · Nov 26, 2025
• Nanox Sells Shares in $15M Direct Offering — 6-K · Nov 24, 2025 Risk: medium
  On November 23, 2025, Nano-X Imaging Ltd. (Nanox) entered into a securities purchase agreement with a single institutional investor to sell 3,826,530 ordinary s
• Nano-X Imaging Ltd. Files 6-K with Financial Results — 6-K · Nov 20, 2025 Risk: low
  On November 20, 2025, Nano-X Imaging Ltd. issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release details the Company's financial
• Nano-X Imaging Files 6-K, Announces Press Release — 6-K · Nov 19, 2025 Risk: low
  On November 19, 2025, Nano-X Imaging Ltd. (NNOX) filed a Form 6-K to report the issuance of a press release dated November 19, 2025. This filing is a routine re
• Nano-X Imaging Sets Shareholder Meeting Date — 6-K · Nov 17, 2025 Risk: low
  Nano-X Imaging Ltd. announced it will hold its Annual General Meeting of Shareholders on December 22, 2025, at 3:00 p.m. Israel time. The meeting will take plac
• Nano-X Imaging Ltd. Files 6-K with Non-GAAP Financials — 6-K · Aug 12, 2025 Risk: medium
  On August 12, 2025, Nano-X Imaging Ltd. (the "Company") issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release includes financia
• Nano-X Imaging Reports Q1 2025 Results and Business Update — 6-K · May 22, 2025 Risk: low
  Nano-X Imaging Ltd. announced its first quarter results for the period ended March 31, 2025, and provided a business update on May 22, 2025. The company is a fo
• Nano-X Imaging Gets FDA Clearance for Nanox.ARC X — 6-K · Apr 17, 2025 Risk: medium
  On April 17, 2025, Nano-X Imaging Ltd. announced it received 510(k) clearance from the U.S. FDA for its Nanox.ARC X system. This clearance allows for the produc
• Nano-X Imaging Files 2024 Annual Report — 20-F · Apr 9, 2025 Risk: medium
  Nano-X Imaging Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, incorporated in Israel, is involved in the X-
• Nano-X Imaging Ltd. Files 6-K with Non-GAAP Financial Measures — 6-K · Mar 31, 2025 Risk: medium
  On March 31, 2025, Nano-X Imaging Ltd. (the "Company") issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release includes financial
• Nano-X Imaging Gets CE Mark for Nanox.ARC System — 6-K · Feb 25, 2025 Risk: medium
  On February 25, 2025, Nano-X Imaging Ltd. announced it has received CE mark certification for its Nanox.ARC system and Nanox.CLOUD. This certification allows th
• Nano-X Imaging Ltd. Shareholders Approve All Proposals at AGM — 6-K · Dec 13, 2024 Risk: low
  Nano-X Imaging Ltd. held its Annual General Meeting of Shareholders on December 10, 2024, in Petach Tikva, Israel. Shareholders approved all proposals presented
• Nano-X Imaging Receives FDA 510(k) Clearance for Nanox.ARC — 6-K · Dec 5, 2024 Risk: medium
  On December 5, 2024, Nano-X Imaging Ltd. announced it received 510(k) clearance from the FDA for its Nanox.ARC stationary X-ray system. This system is designed
• Nano-X Imaging AGM Adjourned Due to Lack of Quorum — 6-K · Dec 3, 2024 Risk: medium
  Nano-X Imaging Ltd. held its Annual General Meeting of Shareholders on December 3, 2024, but it was adjourned for one week due to a lack of quorum. The meeting
• Nano-X Imaging Ltd. Files 6-K, Mentions Non-GAAP Measures — 6-K · Nov 21, 2024 Risk: medium
  On November 21, 2024, Nano-X Imaging Ltd. issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release includes financial measures not
• SC 13G Filing — SC 13G · Nov 8, 2024
• Nano-X Imaging Sets Shareholder Meeting for Dec 3 — 6-K · Oct 29, 2024 Risk: low
  Nano-X Imaging Ltd. announced its Annual General Meeting of Shareholders will be held on Tuesday, December 3, 2024, at 3:00 p.m. Israel time. The meeting will t
• SC 13G Filing — SC 13G · Oct 24, 2024
• Nano-X Imaging Ltd. Holds Analyst Day, Discusses Future Products — 6-K · Sep 23, 2024 Risk: medium
  On September 20, 2024, Nano-X Imaging Ltd. held an Analyst Day to discuss its commercial, clinical, and regulatory progress. The company also provided an outloo
• Nano-X Imaging Ltd. Files 6-K with Non-GAAP Financials — 6-K · Aug 20, 2024 Risk: medium
  On August 20, 2024, Nano-X Imaging Ltd. issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release includes financial measures that
• Nano-X Imaging Director Resigns — 6-K · Jul 26, 2024 Risk: low
  Nano-X Imaging Ltd. announced on July 26, 2024, that Ms. So Young Shin resigned from its Board of Directors effective July 24, 2024, due to personal reasons. Th
• Nano-X Imaging Shareholders Approve All Proposals at Special Meeting — 6-K · Jun 26, 2024 Risk: low
  Nano-X Imaging Ltd. held a Special General Meeting of Shareholders on June 25, 2024, in Petach Tikva, Israel. Shareholders approved all proposals presented in t
• Nano-X Imaging Shareholder Meeting Adjourned Due to Lack of Quorum — 6-K · Jun 18, 2024 Risk: medium
  Nano-X Imaging Ltd. held a Special General Meeting of Shareholders on June 18, 2024, which was adjourned for one week due to a lack of quorum. The meeting will
• Nano-X Imaging Appoints Independent Director Michael Jackman — 6-K · Jun 13, 2024 Risk: low
  On June 13, 2024, Nano-X Imaging Ltd. announced the appointment of Mr. Michael Jackman as a new member of its Board of Directors, effective July 1, 2024. The Bo
• Nano-X Imaging Launches At-the-Market Offering — 6-K · Jun 7, 2024 Risk: medium
  On June 7, 2024, Nano-X Imaging Ltd. entered into a Sales Agreement with Cantor Fitzgerald & Co. and Mizuho Securities USA LLC. This agreement allows the compan
• Nano-X Imaging Ltd. Files 6-K with Non-GAAP Financial Measures — 6-K · May 28, 2024 Risk: low
  On May 28, 2024, Nano-X Imaging Ltd. (the "Company") issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release includes financial m
• Nano-X Imaging to Hold Special Shareholder Meeting June 18 — 6-K · May 8, 2024 Risk: low
  Nano-X Imaging Ltd. announced it will hold a Special General Meeting of Shareholders on Thursday, June 18, 2024, at 3:00 p.m. Israel time. The meeting will take
• Nano-X Imaging Ltd. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Apr 22, 2024 Risk: low
  Nano-X Imaging Ltd. (NNOX) filed a Foreign Annual Report (20-F) with the SEC on April 22, 2024. Nano-X Imaging Ltd. filed its annual report on Form 20-F for the
• Nano-X Imaging Ltd. Files 6-K, Includes Non-GAAP Measures — 6-K · Apr 1, 2024 Risk: low
  On April 1, 2024, Nano-X Imaging Ltd. (the "Company") issued a press release, attached as Exhibit 99.1 to this 6-K filing. The press release includes financial
• SC 13G/A Filing — SC 13G/A · Mar 7, 2024
• Nano-X AI Software HealthFLD Receives FDA 510(k) Clearance — 6-K · Feb 13, 2024 Risk: low
  On February 13, 2024, Nano-X Imaging Ltd. announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd., received 510(k) clearance from t
• BlackRock Discloses Passive Stake in Nano-X Imaging (NNOX) — SC 13G · Feb 6, 2024
  BlackRock Inc., a major investment firm, filed an SC 13G on February 6, 2024, disclosing its ownership of Nano-X Imaging Ltd. (NNOX) common stock as of December
• NANO-X IMAGING APPOINTS CEO EREZ MELTZER AS ACTING CHAIRMAN — 6-K · Jan 25, 2024
  Nano-X Imaging Ltd. (NNOX) announced on January 25, 2024, that its Board of Directors appointed Mr. Erez Meltzer, the current CEO, as acting Chairman, following
• NANO-X IMAGING LTD. Founder Ran Poliakine Dies — 6-K · Jan 16, 2024
  Nano-X Imaging Ltd. (NASDAQ: NNOX) announced on January 16, 2024, that its founder and non-executive chairman, Ran Poliakine, passed away on January 12, 2024, d
• NANO-X Faces New Israeli Lawsuit Over Previously Dismissed US Claims — 6-K · Jan 2, 2024
  Nano-X Imaging Ltd. (NANO-X) announced on January 2, 2024, that a claim was filed in Israel against the company, Nano-x Imaging PLC (Nanox Gibraltar), and Chair

Risk Profile

Risk Assessment: Of NNOX's 31 recent filings, 0 were flagged as high-risk, 14 as medium-risk, and 17 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

• So Young Shin
• Michael Jackman
• Erez Meltzer

Industry Context

Nano-X Imaging Ltd. operates in the medical imaging technology sector, focusing on developing and commercializing novel X-ray technologies.

Top Tags

corporate-governance (9) · shareholder-meeting (8) · filing (6) · financial-reporting (5) · adjournment (3) · 6-K (3) · press-release (3) · non-GAAP (3) · medical-device (3) · non-gaap (3)

Key Numbers

• Filing Acceptance Date: 2026-03-31 — Indicates when the SEC accepted the filing.
• Effectiveness Date: 2026-03-30 — The date the filing became officially effective.
• Shares Sold: 3,826,530 — Number of ordinary shares sold in the direct offering.
• Price Per Share: $3.92 — The price at which each ordinary share was sold.
• Gross Proceeds: ~$15M — Estimated total funds raised before expenses.
• Fiscal Year End: 2024 — The period covered by the annual report.
• SEC File Number: 001-39461 — Unique identifier for the company's SEC filings.
• Filing Date: April 9, 2025 — The date the 20-F was submitted to the SEC.
• Ordinary Shares Outstanding: 57,778,628 — As of December 31, 2023

Related Companies

NXTI · NANO

Frequently Asked Questions